Outside of the aforementioned studies, CBD’s progress toward its place in society today suffered from intermittent spurts and starts until 1996 when California became the first US state to legalize medical cannabis. This groundbreaking moment paved the way for public support and lucrative research opportunities. Other states including Oregon, Alaska, Washington, Maine, Hawaii, Nevada, and Colorado would follow suit before the close of 2000.

One main asset of this serum is the scent, a dusky, spicy confluence of rich notes like spikenard, frankincense, myrrh, and lavender. These ingredients, and more, are informed by tenets of Ayurvedic and herbalist medicine, all of which are meant to complement the effects of the CBD extract with their energizing, anti-anxiety, and analgesic properties. 
The problem here is that the FDA views this clinical indication as statistically significant for patients with Dravet syndrome and Lennox-Gastaut syndrome, and unconfirmed for every other possible ailment. Even with university-based data suggesting that CBD treatments can help with chronic pain or glaucoma, that's not been proven by an FDA-cleared study. And since the "F" in the FDA stands for "Food," adding an unproven substance to food items creates a big gray area for the time being.
Before thing’s started getting out of hand with chronic pain really settling in, I used CBD oil for about a year. I kept waiting and waiting to feel better. Until I just couldn’t take the pain any longer. Than I tried Herion. I did not like that at all, pluse was a little frightened of it. Than I finally asked for pain meds. I just had to find the right dosage. Was doing very good with it. Than I was cut cut back to guidelines, now not so good again. So now what? Their he’ll bent on making Kratom illegals. They just want us all to suffer and die, I’m convinced.
CBD, known scientifically as cannabidiol, is the second most commonly occurring cannabinoid within the marijuana plant, ranking in just below THC, or tetrahydrocannabinol. What is unique and distinctive about CBD, unlike THC this component produces zero psychoactive effects, meaning that it does not create the typical high and euphoria that is linked with marijuana. Furthermore, it has proved to generate immense healing and a multitude of medically beneficial abilities. CBD helps pain on an anatomical level by directly targeting the body’s endocannabinoid system (ECS), which naturally produces some cannabinoids on its own, known as endocannabinoids.
Epilepsy. A specific cannabidiol product (Epidiolex, GW Pharmaceuticals) has been shown to reduce seizures in adults and children with various conditions that are linked with seizures. This product is a prescription drug for treating seizures caused by Dravet syndrome or Lennox-Gastaut syndrome. It has also been shown to reduce seizures in people with tuberous sclerosis complex, Sturge-Weber syndrome, and febrile infection-related epilepsy syndrome (FIRES). But it's not approved for treating these other types of seizures.
Figure 2. Receptor Systems Involved in CBD’s Potential Therapeutic Applications. CBD interacts, either directly or indirectly, with many different receptor systems in the brain. It indirectly influences the major cannabinoid receptor in the brain by decreasing THC’s ability to stimulate this receptor. It also interacts with a variety of other receptors. A subset of these are shown here. Each red shape represents a different brain receptor that might be found on a neuron. Some of the potential therapeutic applications associated with CBD’s interaction with each receptor system are listed below each receptor.
People who suffer from chronic inflammatory diseases whould really try hempseed oil. Its so rich in omega -3 and omega – 6 fatty acids, which are strongly anti-inflammatory. These essential fatty acids are required by the body to lower systemic inflammation. With regular use, one can clearly see an improvement in inflammation and even pain in conditions like arthritis.
Very few randomized controlled trials (RCTs) have been conducted using smoked cannabis (Campbell et al 2001) despite many anecdotal claims (Grinspoon and Bakalar 1997). One such study documented slight weight gain in HIV/AIDS subjects with no significant immunological sequelae (Abrams et al 2003). A recent brief trial of smoked cannabis (3.56% THC cigarettes 3 times daily) in HIV-associated neuropathy showed positive results on daily pain, hyperalgesia and 30% pain reduction (vs 15% in placebo) in 50 subjects over a treatment course of only 5 days (Abrams et al 2007) (Table 1). This short clinical trial also demonstrated prominent adverse events associated with intoxication. In Canada, 21 subjects with chronic pain sequentially smoked single inhalations of 25 mg of cannabis (0, 2.5, 6.0, 9.5% THC) via a pipe three times a day for 5 days to assess effects on pain (Ware et al 2007) with results the authors termed “modest”: no changes were observed in acute neuropathic pain scores, and a very low number of subjects noted 30% pain relief at the end of the study (Table 1). Even after political and legal considerations, it remains extremely unlikely that crude cannabis could ever be approved by the FDA as a prescription medicine as outlined in the FDA Botanical Guidance document (Food and Drug Administration 2004; Russo 2006b), due to a lack of rigorous standardization of the drug, an absence of Phase III clinical trials, and pulmonary sequelae (bronchial irritation and cough) associated with smoking (Tashkin 2005). Although cannabis vaporizers reduce potentially carcinogenic polyaromatic hydrocarbons, they have not been totally eliminated by this technology (Gieringer et al 2004; Hazekamp et al 2006).

Scott Shannon, M.D., assistant clinical professor at the University of Colorado, recently sifted through patient charts from his four-doctor practice to document CBD’s effects on anxiety. His study, as yet unpublished, found “a fairly rapid decrease in anxiety scores that appears to persist for months,” he says. But he says he can’t discount a placebo effect, especially since “there’s a lot of hype right now.”
If your state has legalized both compounds, look for a cream with 1:1 CBD to THC as well as another cannabinoid BCP (beta-caryophyllene) if possible, which manufacturers have seen better results with, Gerdeman suggests. Try Apothecanna's Extra Strength Relieving Creme ($20; apothecanna.com) or Whoopi & Maya's Medical Cannabis Rub (yes, that's Whoopi Goldberg's line), which was designed specifically for menstrual aches and pains (whoopiandmaya.com).

However, switching to CBD oil from a conventional medication is far from a random stab in the dark. In fact, there was a large scale (and very well-documented) survey carried out less than two years ago that looked at precisely what percentage of patients were able to “swap” their side effect-inducing meds for a 100% natural, cannabis-based therapy.
CBD does not appear to have any psychotropic ("high") effects such as those caused by ∆9-THC in marijuana, but may have anti-anxiety and anti-psychotic effects.[9] As the legal landscape and understanding about the differences in medical cannabinoids unfolds, it will be increasingly important to distinguish "medical marijuana" (with varying degrees of psychotropic effects and deficits in executive function) – from "medical CBD therapies” which would commonly present as having a reduced or non-psychoactive side-effect profile.[9][58]

Hi Colleen, it's almost a year later and I'm wondering how you're doing. I'm experiencing a recurrence of Stage 3 ovarian, originally diagnosed in 2011. I've decided to get some chemo, not sold on another 6 cycles though. As a new MMJ patient, I'm still going to go through with Rick Simpson Oil (THC+CBD,) and I just joined a program with my local dispensary to get CBD capsules for $2 each when I order them at least 30 at a time. I hope you're doing well!! I'm off to do more research on dosing. **NOTE: If you have ANY experience with CBD treatment of ovarian cancer, PLEASE respond. Thank you!!


However, switching to CBD oil from a conventional medication is far from a random stab in the dark. In fact, there was a large scale (and very well-documented) survey carried out less than two years ago that looked at precisely what percentage of patients were able to “swap” their side effect-inducing meds for a 100% natural, cannabis-based therapy.
A. To date, the FDA has not approved a marketing application for marijuana for any indication. The FDA generally evaluates research conducted by manufacturers and other scientific investigators. Our role, as laid out in the Federal Food, Drug, and Cosmetic (FD&C) Act, is to review data submitted to the FDA in an application for approval to assure that the drug product meets the statutory standards for approval.
We start with an exceptionally high-quality lotion which we infuse with our hemp extract.  So, not only will you get the CBD you seek, you will also get a lotion that moisturizes without leaving you feeling greasy.  And, the pleasant aroma is soft and subtle, not overwhelming.  The lotion is ideal for using in larger parts of the body as it is not quite as thick as the cream.  The lotion is able to cover a larger part of the body, although it doesn’t have to be spread out.  It can also be used in smaller areas if that’s what you desire.  This product is made with 100mg of CBD per ounce of product.

CBD For Pain

×